2020亚洲医药研发领袖峰会 发布时间：2020-10-13 - 2020-10-16

The Asia Pharma R&D Leaders Summit 2020 ( ‘ APRDL 2020 ‘ ) will bring in fresh perspectives and establish an efficient platform to discuss about the Trends for Future Global Pharma R&D Revolution and Promoting China Innovation: Emerging Therapeutics Research Innovation and Effective Partnership Model; Promoting China Innovation and Regulatory Landscape; Cellular-Based Immunotherapies ( CAR-T & TCR-T Cell Therapy, CAR-NK, TIL Therapy, iPSC-derived Cell Therapy & Gene-Edited Cell Therapies etc., ); AAV-Based Gene Therapy for Human Diseases; Stem Cell-based Therapies and Regenerative Medicine Development for CNS, Diabetes and Anti-Heart Failure; Advancing Treatment for NASH & Liver Diseases; siRNA Therapeutic; Immuno-Oncology Drug Development and CMO-MAH Integration; Computer-Accelerate Rational Discovery (CARD); Strengthening Pharma R&D Collaboration; Artificial Intelligence Innovation in Drug Discovery and Development; IP Patent Strategies and Funding Investment Opportunities; New Formulation and Process Development, API Manufacturing, Analytical Operations, Genotoxic Impurities in Pharmaceuticals, Best Practices & BE Study of Generic Drugs; Drug Delivery and Formulation Development etc.,...

联系先导，请拨打+86-28-85197385, +1-508-840-9646 

媒体咨询：[email protected]

投资人咨询：[email protected] 

商务拓展咨询：[email protected]